groups at the C-3 position of the cephem nucleus was synthesized and evaluated for antibacterial activity and oral absorption in rats in comparison with cefixime. Of these, the cephalosporins (la and lc) with a lower alkoxycarbonylvinylthio group (Z-form) at the C-3 position showed a potent antibacterial activity against Gram-negative bacteria, improved activity against Staphylococcus aureus as well as good oral absorption in rats. The structure-activity relationships of 1 are also presented.
In the course of our studies on aminothiazole-oxime type cephalosporin antibiotics, so called third Since natural occurring carbapenem antibiotics such as JV-acetyldehydrothienamycin2) and PS-73) have been discovered, the substituent effect of the C-2 vinylthio moiety has been studied extensively4*. However, only a little is knownabout the cephalosporin analogues having a vinylthio group at the C-3 position of cephem nucleus5*.
Thus, we were interested in studying the cephalosporin derivatives (1) (Fig. 1 ) having various vinylthio substituents at the C-3 position as an attempt to find new orally active cephalosporins. This paper describes the synthesis, antibacterial activity and oral absorption in rats of 1.
Chemistry
The new cephalosporins (la~ls) were prepared by the synthetic route as shown in Scheme 1. in DMFin the presence ofA^N-diisopropylethylamine to afford the 3-mercapto derivative (6) . Subsequently, compound6 was treated with various propiolic acid esters, propiolamides or propiolonitrile (7) at low temperature in the presence of A^iV-diisopropylethylamine to give the 3-(2-substituted)vinylthiocephalosporins (9) as a mixture of E and Z isomers (E-Z, 1 :6-8 by XHNMRspectrum) (Method A). The two geometric isomers could be separated by silica gel column chromatography, and the E and Z assignments of the vinyl moiety were based upon the observed coupling constant (/ds= ll Hz, /frans= 15Hz) in *H NMRspectra. Compound9 was also prepared from 5 by an alternative route using silver vinylthiolates (8)5'6) (Method B) with retention of the configuration of the silver vinylthiolates5).
Finally, the protecting groups in 9 were removed by conventional method using TFA and anisole to afford the desired cephalosporin derivatives (1).
Antibacterial
Activity and Oral Absorption The in vitro antibacterial activities of the newcephalosporins (la~ls) against selected Gram-positive and Gram-negative bacteria and their peak serum levels as a measure of gastro-intestinal absorption after oral administration (50mg/kg) to rats are summarized in Table 1 . For comparison, the MICvalues and the peak serum levels of related 3-(substituted)alkylthio analogues (2b and 2c)1} and cefixime7) are listed at the bottom of Table 1 .
Against all the Gram-negative bacteria, these new cephalosporins having various ester, amide, carboxy and cyano groups in the vinylthio moiety at the C-3 position except lb, le and Ih exhibited a potent antibacterial activity comparable to cefixime.
On the other hand, against Gram-positive Staphylococcus aureus 209P JC-1, the cephalosporin derivatives 1c, If, lg and Is having the ethyl-, allyl-and benzyl ester group as well as cyano group, respectively, in the C-3 vinylthio moiety showed more potent activity than the others. Their activities were 4 times greater than that of cefixime. Whencompared with the effect of geometric isomers of the C-3 substituent (la vs. lb), the Z-isomer la was more potent than the £-isomer lb against the Gram-negative bacteria.
It was also found that introduction of the vinylthio group into the C-3 position plays an important role to enhance the antibacterial activity against S. aureus (la, lb vs. 2b, and Is vs. 2c), probably due to an increase of the lipophilicity of the molecule.
In the oral absorption study, compoundsla and lc having a lower alkyl ester such as methyl-and ethyl ester in the vinylthio moiety at the C-3 position displayed much better oral absorption than the other analogues, and their peak serum levels were higher than that of cefixime. Interestingly, the oral absorption of la was muchhigher than those of the corresponding.E-isomer lb and 2b, which is the saturated analogue of the C-3 substituent of la. These results shown in Table 1 indicate that the presence of the lower alkoxycarbonylvinylthio group (Z-form) at the 3-position of the cephalosporin is of importance on oral absorption as well as antibacterial activity.
The representative compoundla in this series possessing the potent in vitro antibacterial activity and good oral absorption in rats was then advanced to a preliminary in vivo efficacy trial by oral admin- Table 2 . In vivo antibacterial activity of la against istration. As shown in Table 2 , the derivative systemic infections in mice induced by £^mc^Co// TM-36.
la showed good in vivo efficacy against a systemic infection in mice induced by Escherichia coli TM-36, though the ED50 value of la was about 2 times higher than that of cefixime. Experimental IR spectra were taken on a Jasco DS-701GIR spectrometer. *H NMR spectra were recorded on a Varian XL-200 NMRspectrometer using TMSor sodium trimethylsilyl propionate-d4 (in D2O) as an internal standard. Mass spectra (MS) were measured on a Jeol JMX-DX303 or JMS-SX102mass spectrometer. Most chromatographic separations were done by using Wako Silica gel C-200 (100~200 mesh, Wako, Japan) or Sephadex LH-20 (Pharmacia, Sweden). Analytical HPLC was performed on a TSK gel LS-410 column (5 //m, 150 x 4.6mm, i.d., Tosoh, Japan) eluted with 35% aq acetonitrile containing tetra-«-amylammonium bromide (lOmmol) and ammonium acetate (lOmmol), flow rate 1.0ml/minute at ambient temperature monitoring UVabsorbance at 290 nm.
In Vitro and In Vivo Antibacterial Activities MICs were determined by the 2-fold agar dilution method using Sensitive Test agar (Eiken, Japan) after incubation at 37°C for 18 hours with an inoculum size 106cfu/ml. Mouseprotecting experiments were conducted by use of male ICR mice 0= 10) infected intraperitoneally with 0.5ml of a bacterial suspension containing 100%or more minimal lethal doses. Hog gastric mucin (5% w/v) was added to the suspension before injection. The test drugs in 5%gumarabic were administered orally 1 hour after the infection. Mortality of the animals was recorded daily over a period of 7 days and the ED50values were calculated by the method of probit8).
Oral Absorption Study
Male SLC/Wister rats (n 3) weighing 180~220 g were fasted overnight and orally dosed with 50 mg/kg of the test compounds. Serum samples were collected at 0.5, 1, 2 and 4hours, respectively, after dosing. Serum levels of the test compoundswere measured by the disc-plate method using Escherichia coli SC 507 or Micrococcus luteus NIHJas a test organism and Sensitive Test agar as the test medium.
To a solution of the 3-methanesulfonyloxycephalosporanic acid Bh ester derivative 51} (2.0g, 1.83 mmol) in DMF(20 ml) were added 70% sodium hydrosulfide (164 mg, 1.1 equiv) and iV,Ar-dtisopropylethylamine (284mg, 1.2equiv) dissolved in DMF(8ml) at -10°C. After being stirred for 30minutes at the same temperature, water (100ml) was added to the reaction mixture, and washed with Et2O (20ml). The aqueous layer was then adjusted to pH 2 with 5%HC1and extracted with EtOAc(100ml). The extract was washed with brine (100 ml), dried (MgSO4) and evaporated. The residue was purified by column chromatography on Sephadex LH-20 (eluent; acetone) to give 660mg (70%) of 6 as a pale yellow powder: 
To a solution of the 3-mercaptocephalosporanic acid Bh ester 6 (500 mg, 0.48 mmol) in CH3CN(8 ml) were added methyl propiolate (61 mg, 1.5equiv) and 7V,7V-diisopropylethylamine (32mg, 0.5equiv) at -20°C, and the reaction mixture was stirred for 1 hour at -20 10°C. Then, 0.5% HC1 (20ml) was added to the reaction mixture and extracted with EtOAc (50ml). The extract was washed with brine (50 ml), dried (MgSO4) and evaporated. The residue was purified by column chromatography on silica gel (eluent; «-hexane-EtOAc, 3 : 2) to yield 300mg (56%) of 9a and 47mg (9%) of 9b, the £-isomer of the C-3 substituent of 9a as a yellow powder, respectively. Compounds9c~9h and 9s were similarly prepared from 6 with propiolic acid esters or propiolonitrile according to the procedure described for 9a. Moreover, compounds9n~9r were also synthesized similarly with propiolamides, but a mixture of CHCl3-MeOH(1 :2) was used as the reaction solvent and the reaction was done at 5~20°C. To a suspension of silver (Z)-carbamoylvinylthiolate 8i (115mg, 0.55mmol) in CH3CN(6ml) was added Nal (330 mg, 4.0 equiv) with stirring at room temperature. Then, a solution of compound 5 (500 mg, 0.83 equiv) in CH3CN(4ml) was added to the reaction mixture at 0°C, and stirred for 30minutes at the same temperature. After the reaction, insoluble materials were removed by filtration and water (30ml) was added to the filtrate, and extracted with EtOAc(50ml). The extract was washed with brine (50ml), and then dried (MgSO4)and evaporated. The residue was purified by column chromatography on silica gel (eluent; CH2C12) to afford 378 mg (75%) of9i as a pale yellow powder: IR (KBr) cm~* 1780 (^-lactam), 1730 
